| 1. |
1. Caplan, A. I (1991) Mesenchymal stem cells. J. Orthop. Res. 9:641–650.
|
| |
| 2. |
2. Haynesworth, S. E., Baber M. A., and Caplan, A. 1. (1992) Cell surface antigens on human marrow-derived mesenchymal cells
are detected by monoclonal antibodies. Bone 13:69–80.
|
| |
| 3. |
3. Lazarus, H. M., Haynesworth, S. E., Gerson, S. L., Rosenthal, N. S., and Caplan, A. 1. 1995. Ex vivo expansion and subsequent
infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic
use. Bone Marrow Transplant 16(4).557–564.
|
| |
| 4. |
4. Pittenger, M. F., Mackay, A. M., Beck, S. C, Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W.,
Craig, S., and Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143–147.
|
| |
| 5. |
5. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. l., and Frolova, G. P. (1968) Heterotopic transplants of bone marrow:
Analysis of precursor cells for osteogenic and haematopoietic tissues. Transplantation 6:230–247.
|
| |
| 6. |
6. Friedenstein, A. J. (1976) Precursor cells of mechanocytes. Int. Rev. Cytol. 47:327–355.
|
| |
| 7. |
7. Owen, M. E. and Friedenstein, A. J. (1988) Stromal stem cells: marrow derived osteogenic precursors. Ciba Found. Symp. 136:42–60.
|
| |
| 8. |
8. Halvorsen, Y. C, Wilkison, W. O., and Gimble, J. M. (2000) Adipose-derived stromal cells their utility and potential in
bone formation. Int J Obes Relat Metab Disord. 24:S41–44.
|
| |
| 9. |
9. Gronthos, S., Franklin, D. M., Leddy, H. A., Robey, P. G., Storms, R. W., and Gimble, J. M. (2001) Surface protein characterization
of human adipose tissue-derived stromal cells. J Cell Physiol. 189:54–63.
|
| |
| 10. |
10. Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C, Eraser, J. K., Benhaim, P.,
and Hedrick, M. H. (2002) Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell.13:4279–295.
|
| |
| 11. |
11. Lodie, T. A., Blickarz, C. E., Devarakonda, T. J., He, C, Dash, A. B., Clarke, J., Gleneck, K., Shihabuddin, L., and Tubo,
R. (2002) Systematic analysis of reportedly distinct populations of multipotent bone marrow-derived stem cells reveals a lack
of distinction. Tissue Eng. 8:739–751.
|
| |
| 12. |
12. Phinney, D. G., Kopen, G., Isaacson, R. L., and Prockop, D. (1999) Plastic adherent stromal cells from the bone marrow
of commonly used strains of inbred mice: variations in yield, growth and differentiation. J. Cell. Biochem. 72:570–585.
|
| |
| 13. |
13. Saito, T., Dennis, J. E., Lennon, D. P., Young, R. G., and Caplan, A. I. (1995) Myogenic expresssion of mesenchymal stem
cells within myotubes of mdx mice in vitro and in vivo. Tissue Engin. 1(4): 327–343.
|
| |
| 14. |
14. Pereira, R. F., Halford, K. W., O'Hara, M. D., Leeper, D. B., Sokolov, B. P., Pollard, M. D., Bagasra, O., and Prockop,
D. J. (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage and lung in
irradiated mice. Proc. Natl. Acad. Sci. USA. 92:4857–4861.
|
| |
| 15. |
15. Dennis, J. E., Merriam, A., Awadalla, A., Yoo, J. U., Johnstone, B., and Caplan, A. 1. (1999) A quadripotent mesenchymal
progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner Res. 14:700–709.
|
| |
| 16. |
16. Short, B., Brouard, N., Driessen, R., and Simmons, P. J. (2001). Prospective isolation of stromal progenitor cells from
mouse BM. Cytotherapy. 3:407, 408.
|
| |
| 17. |
17. Grigoriadis, A. E., Heersche, J., and Aubin, J. E. (1990) Continuously growing bipotential and monopotential myogenic,
adipogenic and chondrogenic subclones isolated from the multipotential RCJ3.1 clonal cell line. Developmental Biology 142:313–318.
|
| |
| 18. |
18. LeBoy, P. S., Beresford, J., Devlin, C, and Owen, M. (1991) Dexamethasone induction of osteoblast mRNAs in rat marrow
stromal cell cultures. J. Cell Physiol. 146:370–378.
|
| |
| 19. |
19. Beresford, J. N., Bennett, J. H., Devlin, C, LeBoy, P. S., and Owen, M. (1992) Evidence for an inverse relationship between
the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102:341–351.
|
| |
| 20. |
20. Kadiyala, S., Jaiswal, N., and Bruder, S. P. (1997) Culture-expanded bone marrow-derived mesenchynal stem cells can regenerate
a critical-sized segmental bone defect. Tissue Engirt. 3:173–185.
|
| |
| 21. |
21. Neuhuber, B., Gallo, G., Howard, L., Kostura, L., Mackay, A., and Fischer, 1. (2004) Reevaluation of in vitro differentiation
protocols for bone marrow stromal cells: disruption of actin cytoskeleton induces rapid morphological changes and mimics neuronal
phenotype. J. Neurosci. Res. 77(2): 192–204.
|
| |
| 22. |
22. Wakitani, S., Goto, T., Pineda, S. J., Young, R. G., Mansour, J. M., Goldberg, V. M., and Caplan, A. I. (1994) Mesenchymal
cell based repair of large, full thickness defects of articular cartilage. J. Bone Joint Surg. 76:579–592.
|
| |
| 23. |
23. Grande, D. A., Southerland, S. S., Ryhanna, Manji, B. S., Pate, D. W., Schwartz, R. E., and Lucas, P. A. (1995) Repair
of articular defects using mesenchymal stem cells. Tissue Engin.1:345–353.
|
| |
| 24. |
24. Young, R. G., Butler, D. L., Weber, W., Caplan, A. 1., Gordon, S. L., and Fink, D. J. (1998) Use of mesenchymal stem cells
in a collagen matrix for achilles tendon repair. J. Orthop. Res. 16:406–413.
|
| |
| 25. |
25. Kadiyala, S., Young, R. G., Thiede, M. A., and Bruder, S. P. (1997) Culture expanded canine mesenchymal stem cells possess
osteochondrogenic potential in vivo and in vitro. Cell Transplant. 6(2): 125–134.
|
| |
| 26. |
26. Kraitchman, D. L., Tatsumi, M., Gilson, W. D., Ishimori, T., Kedziorek, D., Walczak, P., Segars, W. P., Chen, H. H., Fritzges,
D., Izbudak, I., Young, R. G., Marcelino, M., Pittenger, M. F., Solaiyappan, M., Boston, R. C, Tsui, B. M., Wahl, R. L., and
Bulte, J. W. (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation. 112(10):1451–1461.
|
| |
| 27. |
27. Murphy, J. M., Fink, D. J., Hunziker, E. B., and Barry, F. P. (2003). Stem cell therapy in a caprine model of osteoarthritis.
Arthritis Rheum. 48:3464–3474.
|
| |
| 28. |
28. Shake, J. G., Gruber, P. J., Baumgartner, W. A., Senechal, G., Meyers, J., Redmond, J. M., Pittenger, M. F., and Martin,
B. J. (2002) Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann. Thorac. Surg. 73:1919–1925.
|
| |
| 29. |
29. Kraitchman, D. L., Heldman, A. W., Atalar, E., Amado, L. C, Martin, B. J., Pittenger, M. F., Hare, J. M., and Bulte, J.
W. (2003). In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 107(18):2290–2293.
|
| |
| 30. |
30. Amado, L. C, Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., Durand, D. J., Fitton, T., Kuang,
J. Q., Stewart, G., Lehrke, S., Baumgartner, W. W., Martin, B. J., Heldman, A. W., and Hare, J. M. (2005) Cardiac repair with
intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl Acad. Sci. USA. 102(32):11,474–11,479.
|
| |
| 31. |
31. Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., Palasis, M., and Wilensky, R. L. (2006) A quantitative,
randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur. Heart J. 27(9): 1114–1122.
|
| |
| 32. |
32. Mahmud, N., Pang, W., Cobbs, C, Alur, P., Borneman, J., Dodds, R., Archambault, M., Devine, S., Turian, J., Bartholomew,
A., Vanguri, P., Mackay, A., Young, R., and Hoffman, R. (2004) Studies of the route of administration and role of conditioning
with radiation on unrelated allogeneic mismatched mesenchymal stem cell engraftment in a nonhuman primate model. Exp. Hematol. 32(5):494–501.
|
| |
| 33. |
33. Chapel, A., Bertho, J. M., Bensidhoum, M., Fouillard, L., Young, R. G., Frick, J., Demarquay, C, Cuvelier, P., Mathieu,
E., Trompier, F., Dudoignon, N., Germain, C., Mazurier, C., Aigueperse, J.. Borneman, J., Gorin, N. C., Gourmelon, P., and
Thierry, D. (2003). Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-
induced multiorgan failure syndrome. J. Gene Med. 5(12): 1028–1038.
|
| |
| 34. |
34. Devine, S. M., Cobbs, C., Jennings, M., Bartholomew, A., and Hoffman, R. (2003) Mesenchymal stem cells distribute to a
wide range of tissues following systemic infusion into nonhuman primates. Blood. 101(8):2999–3001.
|
| |
| 35. |
35. Bartholomew, A., Patil, S., Mackay, A., Nelson, M., Buyaner, D., Hardy, W., Mosca, J., Sturgeon, C., Siatskas, M., Mahmud,
N., Ferrer, K., Deans, R., Moseley, A., Hoffman, R., and Devine, S. M. (2001) Baboon mesenchymal stem cells can be genetically
modified to secrete human erythropoietin in vivo. Hum. Gene Ther. 12(12):1527–1541.
|
| |
| 36. |
36. Haynesworth SE, Baber MA, and Caplan AI (1996) Cytokine expression by human marrow- derived mesenchymal progenitor cells
in vitro: effects of dex and IL-1α. J. Cell. Physiol. 166: 585–592.
|
| |
| 37. |
37. Majumdar, M. K., Thiede, M. A., Mosca, J. D., Moorman, M., and Gerson, S. L. (1998). Phenotypic and functional comparison
of marrow-derived mesenchymal stem cells and stromal cells. J. Cell Phys. 176:57–66.
|
| |
| 38. |
38. Reese, J. S., Koc, O. N., and Gerson, S. L. (1999) Human mesenchymal stem cells provide stromal support for efficient
CD344+ transduction. J. Hematother. Stem Cell Res. 8:515–523.
|
| |
| 39. |
39. Cheng, L., Hammond, H., Ye, Z., Zhan, X., and Dravid, G. (2003) Human adult marrow cells support prolonged expansion of
human embryonic stem cells in culture. Stem Cells. 21(2):131–142.
|
| |
| 40. |
40. Mackay, A. M., Beck, S. C, Murphy, J. M., Barry, F. P., Chichester, C. O., and Pittenger, M. F. (1998) Chondrogenic differentiation
of cultured human mesenchymal stem cells from marrow. Tissue Eng. 4(4): 415–428.
|
| |
| 41. |
41. Johnstone, B., Hering, T. M., Caplan, A. 1., Goldberg, V. M., and Yoo, J. U. (1998) In vitro chondrogenesis of bone marrow-derived
mesenchymal progenitor cells. Exp. Cell Res. 10;238(l):265–272.
|
| |
| 42. |
42. Jaiswal, R. K., Jaiswal, N., Bruder, S. P., Mbalaviele, G., Marshak, D. R., and Pittenger, M. F. (2000). Adult human mesenchymal
stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J. Biol. Chem. 275(13):9645–9652.
|
| |
| 43. |
43. Bittira, B., Shum-Tim, D., Al-Khaldi, A., and Chiu, R. C. 2003. Mobilization and homing of bone marrow stromal cells in
myocardial infarction. Eur. J. Cardiothorac. Surg. 24(3):393–398.
|
| |
| 44. |
44. Pittenger, M. F., and Martin, B. J. (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ. Res. 95(l):9–20.
|
| |
| 45. |
45. Francois, S., Bensidhoum, M., Mouiseddine, M., Mazurier, C, Allenet, B., Semont, A., Frick, J., Sache, A., Bouchet, S.,
Thierry, D., Gourmelon, P., Gorin, N. C,, and Chapel, A. (2006). Local irradiation not only induces homing of human mesenchymal
stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution
after irradiation damage. .Stem Cells. 24:1020–1029.
|
| |
| 46. |
46. Klyushnenkova, E., Mosca, J. D., Zernetkina, V., Majumdar, M. K., Beggs, K. J., Simonetti, D. W., Deans, R. J., and Mcintosh,
K. R. (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci.12(l):47–57.
|
| |
| 47. |
47. Di Nicola, M., Carlo-Stella, C, Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., and Gianni, A.M.
(2002) Human bone marrow stromal cells suppress T-lym-phocyte proliferation induced by cellular or nonspecific mitogenic stimuli.
Blood. 99 (2002), 3838–3843.
|
| |
| 48. |
48. Aggarwal, S., and Pittenger, M. F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 105(4):1815–1822.
|
| |
| 49. |
49. Le Blanc, K., and Pittenger, M. F. (2005) Mesenchymal stem cells: progress toward promise. Cytotherapy. 7(1):36–45.
|
| |
| 50. |
50. Groh, M. E., Maitra, B., Szekely, E., and Koc, O.N. (2005) Human mesenchymal stem cells require monocyte-mediated activation
to suppress alloreactive T cells. Exp. Hemat. 33(8):928–934.
|
| |
| 51. |
51. Le Blanc, K., Rasmusson, 1., Sundberg, B., Gotherstrom, C, Hassan, M., Uzunel, M., and Ringden, O. (2004) Treatment of
severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 363(9419):1439–1441.
|
| |
| 52. |
52. Horwitz, E. M., Gordon, P. L., Koo, W. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., and Hofmann, T. (2002) Isolated
allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications
for cell therapy of bone. Proc. Natl Acad. Sci. USA.99 (13).8932–8937.
|
| |
| 53. |
53. Le Blanc, K., Gotherstrom, C., Ringden, O., Hassan, M., McMahon, R., Horwitz, E., Anneren, G., Axelsson, O., Nunn, J.,
Ewald, U., Norden-Lindeberg, S., Jansson, M., Dalton, A., Astrom, E., and Westgren, M. (2005) Fetal mesenchymal stem-cell
engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 79(11):1607–1614.
|
| |
| 54. |
54. Koc, O. N., Day, J., Nieder, M., Gerson, S. L., Lazarus, H. M., and Krivit, W. (2002) Allogeneic mesenchymal stem cell
infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 30(4):215–222.
|
| |